MaveriX Oncology
Latest round
- Series A
Last raised
- Oct 2019
Total raised
- $6.5M
Investors
- 1
About MaveriX Oncology
MaveriX Oncology, Inc.Founded in 2014 and headquartered in Palo Alto, US, MaveriX Oncology specializes in creating targeted therapies for oncology.5 mn.MaveriX Oncology specializes in the development of novel targeted therapeutics aimed at treating solid tumors, utilizing Conditionally Activated Small Molecule Therapeutics. This approach focuses on co-targeting both cancerous cells and the tumor immune microenvironment, which is critical in enhancing treatment efficacy and minimizing side effects.MaveriX Oncology operates on a B2B model, engaging in partnerships with healthcare institutions and pharmaceutical companies to deliver its therapeutics. The revenue structure involves licensing agreements and collaborative research initiatives, wherein clients may subscribe to ongoing development programs or purchase therapeutic candidates as they progress through clinical trials.5 mn from PPF Group to advance its product pipeline and expand its market presence. The company is focused on launching new therapeutics designed to target solid tumors and aims to enter additional markets across Europe and North America by 2023. This strategic expansion is aimed at addressing the needs of underserved patient populations and enhancing its collaborative efforts with healthcare institutions.
Who invested in MaveriX Oncology
1 investor across 1 round
See all investors in MaveriX Oncology
Sign up free to see every VC on the cap table, the rounds they joined, and how much each round raised.
Funding rounds
Series A
Oct 14, 2019
Amount
$6.5M
Investors
Questions about MaveriX Oncology
Who invested in MaveriX Oncology?
MaveriX Oncology has 1 investor on record across 1 venture round. Sign up free to see every VC on the cap table and the rounds they joined.
How much funding has MaveriX Oncology raised?
MaveriX Oncology has raised 1 venture round. Sign up free to see how much each round raised and the total.
When did MaveriX Oncology last raise money?
MaveriX Oncology's most recent round on record is a Series A, in Oct 2019.
What does MaveriX Oncology do?
MaveriX Oncology is a biotechnology company.
Where is MaveriX Oncology headquartered?
MaveriX Oncology is headquartered in Palo Alto, US.
Which VCs invest in companies like MaveriX Oncology?
Among active investors with capital left to deploy, Andreessen Horowitz, Founders Fund, Accel and Thrive Capital back biotechnology companies at MaveriX Oncology's stage. Their profiles are linked below.
VCs backing biotechnology startups at Series A
Raising like MaveriX Oncology? Find the right VCs.
Capital Atlas matches your startup to active investors by stage, sector and region.